Shire Falls Most Since 2003 on Actavis’s Adderall Generic

Shire Plc fell the most in more than nine years after U.S. drug regulators unexpectedly approved a copycat version of its second-biggest selling drug.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.